Table 1.
Scaffold Base | Additional Compounds | Cell Type | Compression Parameters | Compression Duration | Results after Compression |
Reference |
---|---|---|---|---|---|---|
Collagen | Collagen I | Human MSCs |
10% peak compressive sinusoidal strain at 1 Hz frequency | 2 h/day, 1, 4, 7, 14 and 21 days | Upregulated cartilage specific genes: AGG, COL2A1 and SOX9, and prevented expression of COL10A1, and COL1A2. | [80] |
Collagen I | Human MSCs | 1% amplitude sinusoidal strain at the three frequencies of 0.01, 0.1, 1 Hz for 10 cycles at each frequency | - | Resistance to compression, increased dynamic properties of the scaffold, more marked viscoelastic behavior over time | [81] | |
Alginate | Human MSCs | 10% or 15% cyclic compressive strain | 4 out of 24 h for up to 21 days | Increased expression of CBFA-1, Sox9, and aggrecan under 15% cyclic compressive strain alone | [82] | |
Chondroitin sulfate | PEG | Human MSCs | Dynamic loading from 0% to 15% amplitude strain in a sinusoidal waveform at a frequency of 0.3 Hz | 0.5 h on, 1.5 off, repeated for 16 h followed by 8 h off, during 1 week | Downregulated Col X, RUNX2 and collagen I/II protein expression | [83] |
PEG | Human MSCs | Dynamic loading 5% strain 0.3 Hz (1.5% s−1); 10% strains 0.3 Hz (3% s−1); 5% strain 1 Hz (5% s−1); 10% strain 1 Hz (10% s−1)). | 1 h/day for a week | Upregulated collagen II gene expression | [84] | |
Hyaluronic acid | Fibrin | Human MSCs | Compressive modulus at 20% strain, 3.39 ± 0.91 kPa to 6.76 ± 0.52 kPa | - | Eased collagen type 1 expression and an increase Sox9 expression | [85] |
Hyaluronan- gelatin composites |
Human BMMSCs |
4 h/day in the first 7 days of culture | Proteoglycan and collagen contents were significantly higher in the loaded samples compared to unloaded controls | [86] | ||
Fibrin | Rabbit BMMSCs | Mechanical compression of low-intensity ultrasound (LIUS) | 4 weeks of LIUS (1.0 MHz and 200 mW/cm2) | LIUS induces chondrogenic differentiation of MSCs without TGF-ß3 treatment and increased chondrogenic markers | [87] | |
Methacrylate | Calve BMMSCs | 0.02 N for 5 min to 1000 sec relax and 1% sinusoidal deformation at 1.0 Hz | 3, 7, 21, 63 days | Increase in GAG production after 63 days under mechanical load | [88] | |
Chitosan | Collagen | Rabbit chondrocytes | Cyclic compression of 40% stain, 0.1 Hz | 30 min/day for two weeks | Enhanced cells proliferation and GAGs deposition. 82% degree of chitosan deacetylation | [89] |
Oxidized dextran, and teleostean | Human MSCs | 0.02 N preload for 500 sec, this consisted of 20% stain, 2 Hz, 0.12 and 0.96 MPa | 42 days | Upregulation of aggrecan and collagen II mRNA, and increased GAG and collagen content. 85% degree of chitosan deacetylation | [90] | |
Agarose | Human MSCs | Dynamic compression loading was applied at 1 Hz | 1 h/day, 14 days. | Total GAG content and GAG/DNA content was significantly higher, as compared to unloaded control. |
[91] | |
Silk fibrin and nano- hydroxyapatite |
Rat BMMSCs | 10% compressive strain, 0.5 Hz | 2 h action + 4 h pause/cycle, 4 cycles/day | Upregulation of chondrogenesis markers (Aggrecan, Sox-9, and collagen II. 92( ± 2.1)% degree of chitosan deacetylation | [92] | |
Alginate | - | Rabbit adipose-derived MSCs | 1 Hz, with air pressure 21 kPa and different stain magnitudes (0–20%). | 2 h per day, 6 days a week | Expression of Col II, SOX9 and aggrecan w/o TGF-ß | [93] |
- | Human MSCs | 0.5 Hz frequency and 6813 ± 2195 Pa | 21 d. | SOX9 and aggrecan gene expression of uncompressed group was low and increased 15 fold and 7 fold, respectively, for compressed group | [94] |